Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Utilizing TRIPS Flexibilities for Public Health Protection Through South-South Regional Frameworks
(2004; 110 pages) [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoTHE SOUTH CENTRE
Ver el documentoPREFACE
Ver el documentoABBREVIATIONS
Ver el documentoEXECUTIVE SUMMARY
Abrir esta carpeta y ver su contenidoI. INTRODUCTION
Abrir esta carpeta y ver su contenidoII. INTELLECTUAL PROPERTY AND ACCESS TO ESSENTIAL MEDICINES IN DEVELOPING COUNTRIES
Abrir esta carpeta y ver su contenidoIII. CONSTRAINTS ON NATIONAL EFFORTS TO IMPLEMENT TRIPS FLEXIBILITIES FOR PUBLIC HEALTH PURPOSES
Abrir esta carpeta y ver su contenidoIV. OVERCOMING CONSTRAINTS IN THE USE OF TRIPS FLEXIBILITIES THROUGH SOUTH-SOUTH REGIONAL FRAMEWORKS
Abrir esta carpeta y ver su contenidoV. CONCLUSIONS AND RECOMMENDATIONS
Ver el documentoBIBLIOGRAPHY
Ver el documentoBACK COVER
 

BIBLIOGRAPHY

Abbott, F., (1998) "First report (final) to the Committee on International Trade Law of the International Law Association on the Subject of Parallel Importation", Journal of International Economic Law, 607.

Abbott, F., (2001) "The TRIPS Agreement, Access to Medicines and the WTO Doha Ministerial Conference", Occasional Paper 7, QUNO, Geneva.

Abbott, F., (2002) "Compulsory Licensing for Public Health Needs: The TRIPS Agenda at the WTO after the Doha Declaration on Public Health", Occasional Paper 9, QUNO, Geneva.

Abu Mansor, S., and A. Radam, (2000) "ASEAN Industrial Cooperation and Intra ASEAN Trade: The Malaysian Case". Available at http://www.econ.upm.edu.my/report/ecn0009.pdf.

Ackiron, E., "Patents for Critical Pharmaceuticals: The Case of AZT" (1991) 17 American Journal of Medicine and Law 145.

African Development Bank (ADB) and African Development Fund (ADF), (2000) "Economic Cooperation and Regional Integration Policy" ADB/ADF, Abidjan.

Bailey, M., (2001), Priced Out of Reach: How WTO Patent Policies Will Reduce Access to Medicines in the Developing World, Oxfam Briefing Paper 4. Available at http://www.tradeobservatory.org/library/uploadedfiles,html.

Balance, R., J. Pogany, and H. Forstner, (1992) The World's Pharmaceutical Industry: An International Perspective on Innovation, Competition and Policy. Ashgate Publishers, Brookfield.

Balasubramaniam, K. (2002), "Access to Medicines and Public Policy Safeguards under TRIPS", Multi-Stakeholder Dialogue on Trade, Intellectual Property and Biological Resources in Asia, Bangladesh, April 19-20, mimeo.

Bouzas, R. and J. Ros, (1994) Economic Integration in the Western Hemisphere, University of Notre Dame.

Burnett, F., (2001) "The OECS Pharmaceutical Procurement Service: Reducing the Cost of Pharmaceuticals through Multi-state Pooled Procurement". Presentation delivered during the 13th Commonwealth Health Ministers Meeting, 25-29 November, 2001, New Zealand.

Correa, C., (1999a) "Intellectual Property Rights and the Use of Compulsory Licences: Options for Developing countries", T. R. A. D. E Working Papers 5, South Centre, Geneva.

Correa, C., (1999b) Intellectual Property Rights, the WTO and Developing Countries: The TRIPS Agreement and Policy Options, ZED Books, London.

Correa, C., (2000) Integrating Public Health Concerns into Patent Legislation in Developing Countries, South Centre, Geneva.

Correa, C., (2002) Protection of Data Submitted for the Registration of Pharmaceuticals: Implementing the Standards of the TRIPS Agreement, South Centre/EDM-WHO, Geneva.

Grubb, P., (1999) Patents for Chemicals Pharmaceuticals and Biotechnology: Fundamentals of Global Law, Practice and Strategy, Clarendon Press, Oxford.

Inter-American Development Bank, Serie Red Int. (2000) "El Impacto Sectorial del Proceso de Integración Sub-Regional En El MERCOSUR: Sector Farmacéutico".

Kaplan, W.A., R. Laing, B. Waning, L. Levison and S. Foster, (2003) "Is Local Production of Pharmaceuticals A Way to Improve Pharmaceutical Access in Developing and Transitional Countries? Setting a Research Agenda", Boston School of Public Health, mimeo.

Lahouel, M., and K. Maskus, (1999), Competition Policy and Intellectual Property Rights in Developing Countries: Interests in Unilateral Initiatives and a WTO Agreement.

Lettington, R. and Musungu, S., (2000) "In Defence of Kenya’s Health: Proposed Amendments to the Industrial Property Bill 2000", Kenya Coalition for Access to Essential Medicines, Nairobi, mimeo.

Love, J. (2001), "Compulsory Licensing: Models for State Practice in Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord", Consumer Project on Technology, Washington D.C. Available at http://www.cptech.org/ip/health/cl/recommended stateprac-tice.html.

Medecins Sans Frontieres (MSF) Drugs for Neglected Diseases Working Group and Campaign for Access to Essential Medicines (2001) Fatal Imbalance: The Crisis in Research and Development for Drugs for Neglected Diseases, MSF, Geneva.

MSH (2002), "Regional Pooled Procurement of Drugs: Evaluation of Programs", mimeo.

MSH (2003), "Regional Pooled Procurement of Drugs in Sub-Saharan Africa" mimeo

Musungu, S. and G. Dutfield, (2003) "Multilateral Agreements and a TRIPS-plus World: The World Intellectual Property Organization (WIPO)", QUNO, Geneva/QIAP, Ottawa.

NIHCM Foundation, (2002) Changing Patterns of Pharmaceutical Innovation, NIHCM Foundation, Washington, D.C.

Okediji, R., (forthcoming 2004) "Rules of Power in an Age of Law: Process Opportunism and TRIPS Dispute Settlement" in Choi, K and J. Hartigan (eds.) Handbook of International Trade Law.

Reichman, J., (2003) "Managing the Challenges of a Globalized Intellectual Property Regime", paper presented at the Second Bellagio Series of Dialogues 18 to 21 September 2003 Bellagio, organized by UNCTAD and ICTSD. Available at http://www.iprsonline.org/unctadictsd/bellagio/dialogue2003/bell2_docs.htm.

Reichman, J. and C. Hasenzahl (2003) "Non-voluntary Licensing of Patent Inventions: Historical Perspective, Legal Framework under TRIPS, and an Overview of the Practice in Canada and the USA", Issue Paper 5, ICTSD and UNCTAD.

Reichman, J., Watal J. and R. Okediji (2000) UNDP Flagship Programme on IPRs, Traditional Knowledge and Bioresources, UNDP, New York.

Rosamond, B., (2003) "Regional Integration in Europe and Asia". Available at http://www.ias.nl/asem/publications/Rosamond_RegionalIntegration.pdf

Sell, S., (2002) "TRIPS and the Access to Medicines Campaign", Wisconsin International Law Journal vol. 20, No. 3, 481.

South Commission (1990), The Challenge to the South, Oxford University Press, New York.

t’Hoen, Ellen, (2002) "TRIPS, Pharmaceutical Patents and Access to Essential Medicines: A Long Way from Seattle to Doha", Chicago Journal of International Law, vol. 3, No.1 Spring.

UNAIDS "AIDS Epidemic Update 2003". Available at http://www.unaids.org.

Vandoren, P., and J. Van Eeckhaute, (2003) "The WTO Decision on Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health-Making it Work", 6 J.W.I.P., 779-793.

Velasquez, G. and P. Boulet, (1999), Globalization and Access to Drugs: Perspectives on the WTO/TRIPS Agreement, Health Economics and Drugs, DAP Series No. 7, WHO, Geneva.

Venables, A., (2000) "International Trade; Regional Economic Integration" an article prepared for the International Encyclopaedia of Social and Behavioural Sciences. Available at http://econ.lse.ac.uk/staff/ajv/regenc2.pdf.

Vivas-Eugui, D., (2003), Regional and Bilateral Agreements and a TRIPS-Plus World: the Free Trade Area of the Americas (FTAA), QUNO, ICTSD, Geneva and QIAP, Ottawa.

Weissman, R., (2003) "TRIPS-plus Conditions in Bilateral Trade Agreements", mimeo.

WTO (1999) The Legal Texts: The Results of the Uruguay Round of Multilateral Trade Negotiations, Cambridge University Press, Cambridge.

Yang, J., (2002), "Regionalism in Asia: Trends and Prospects", Paper prepared for the Workshop on Asian Regionalism and US-China-Japan Relations. Available at http://www.siis.org.cn/english/journal/j02/jmyang4.htm,

 

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019